Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 9, 2021
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
Yatin Suneja Downgraded (ACAD) to Hold on, Mar 9th, 2021
Yatin Suneja of Guggenheim, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold on, Mar 9th, 2021.
Yatin has made no other calls on ACAD in the last 4 months.
There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Yatin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yatin
- Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020
